Identification of HLA class I dependent immunogenic peptides from clonotypic TCRβ expressed in cutaneous T-cell lymphoma

International Journal of Cancer

Volumn 119, Issue 10, 2006, Pages 2476-2480

  Zeng, Jinyang ^a,b   Müller Berghaus, Jan ^a,b   Nguyen, Xuan Duc ^c   Klüter, Harald ^c   Schönhaber, Hiltrud ^b   Song, Mingxia ^a,b   Schwinn, Nicole ^a,b   Schadendorf, Dirk ^a,b   Goerdt, Sergij ^b   Eichmüller, Stefan ^a,b   Dippel, Edgar ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Institute of Transfusion Medicine and Immunology   (Germany)

Author keywords

Cutaneous T cell lymphoma; Immunotherapy; Reverse immunology; T cells

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; MOLECULAR RECOGNITION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECOMBINANT PLASMID; SEZARY CELL; T LYMPHOCYTE; TUMOR CELL;

EPITOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-A2 ANTIGEN; HLA-A3 ANTIGEN; HUMANS; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, T-CELL, CUTANEOUS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 33749598675     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22113     Document Type: Article

References (22)

1. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
2. Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann NY Acad Sci 2001;941:1-11.
3. Dummer R, Häffner A, Hess M, Burg G. A rational approach to the therapy of cutaneous T-cell lymphomas. Onkologie 1996;19:226-30.
4. Dippel E, Klemke CD, Goerdt S. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions. Onkologie 2003;26:477-83.
5. Eichmüller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA 2001;98:629-34.
6. Hartmann TB, Thiel D, Dummer R, Schadendorf D, Eichmüller S. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma. Br J Dermatol 2004;150:252-8.
7. Dippel E, Assaf C, Hummel M, Schrag HJ, Stein H, Goerdt S, Orfanos CE. Clonal T-cell receptor γ-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol 1999;188:146-54.
8. Reddy SA, Okada C, Wong C, Bahler D, Levy R. T cell antigen receptor vaccines for active therapy of T cell malignancies. Ann NY Acad Sci 2001;941:97-105.
9. Berger CL, Longley J, Hanlon D, Girardi M, Edelson R. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma. Ann NY Acad Sci 2001;941:106-22.
10. Winter D, Fiebiger E, Meraner P, Auer H, Brna C, Strohal R, Trautinger F, Knobler R, Fischer GF, Stingl G, Maurer D. Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma. J Immunol 2003;171:2714-24.
11. Sandberg Y, Heule F, Lam K, Lugtenburg PJ, Wolvers-Tettero IL, van Dongen JJ, Langerak AW. Molecular immunoglobulin/T-cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol. Haematologica 2003;88:659-70.
12. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
13. Sun Y, Song M, Stevanovic S, Jankowiak C, Paschen A, Rammensee HG, Schadendorf D. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen. Int J Cancer 2000;87:399-404.
14. Muller-Berghaus J, Olson WC, Moulton RA, Knapp WT, Schadendorf D, Storkus WJ. IL-12 production by human monocyte-derived dendritic cells: looking at the single cell. J Immunother 2005;28:306-13.
15. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135-42.
16. Paschen A, Jing W, Drexler I, Klemm M, Song M, Muller-Berghaus J, Nguyen XD, Osen W, Stevanovic S, Sutter G, Schadendorf D. Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2. Int J Cancer 2005;116:944-8.
17. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6.
18. DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol 1993;151:5930-5.
19. Berger CL, Longley BJ, Imaeda S, Christensen I, Heald P, Edelson RL. Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor. Int J Cancer 1998;76:304-11.
20. Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 2005;105:1640-7.
21. Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH et al. Paucity of FOXP3(+) cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas. Leukemia 2006;20:1123-9.
22. Orentas RJ, Kohler ME, Johnson BD. Suppression of anti-cancer immunity by regulatory T cells: back to the future. Semin Cancer Biol 2006;16:137-49.